Volver a Agenda
Session # 2 FUTURISTIC PRECLINICAL DEVELOPMENT – TRENDS AND OPPORTUNITIES
Session Chair(s)
Kiran Marthak, MD, FFPM, FRCP
Director, Phase 1 & Regulatory
Lambda Therapeutic Research Ltd., India
Charu Gautam, MD
Senior Director- Medical Science and Strategy
IQVIA, India
Speaker(s)
CENTRAL ROLE OF DMPK IN DRUG DESIGN AND DEVELOPMENT
Ramachandra Sangana
Novartis, India
Senior Investigator, PK Sciences
ROLE OF GENOMICS AND BIOMARKERS IN DRUG DISCOVERY AND DEVELOPMENT
Pramod Kabra, MD
Thermofisher, India
Director, Healthcare- India and South Asia
¿Tiene una cuenta?